EUVIMEDEUVIMED entdecken
CrossrefInfokarte

When extended metabolites profiling helps the prediction of local relapse in glioblastoma: a retrospective study using MRI and MRSI

Wafae Labriji, Amel Aissaoui, Jean-Yves Tourneret, Lotfi Chaari, Lucie Piram, Umberto Sabatini, Anthony Lemarié, Elizabeth Moyal Cohen-Jonathan, Soléakhéna Ken

British Journal of Radiology · 2026-10-19

DOI: 10.1093/bjr/tqag247 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives This study investigates whether integrating postoperative MRI with advanced MR spectroscopic imaging (MRSI) improves voxel-wise prediction of future local recurrence in glioblastoma (GBM). Methods Fifty-eight GBM patients included in the clinical trial Spectro-Glio were retrospectively analyzed with post-operative baseline for MRI and MRSI processed to generate voxel-level features. MRSI metabolites were quantified using a Bayesian sparse model, enabling reliable estimation of both conventional and extended metabolite panels. Ground-truth relapse labels were derived from longitudinal follow-up MRI to track voxel-wise tissue class changes over time. Voxel-wise relapse prediction was performed using 3 supervised classifiers (Elastic Net, Random Forest, RBF-SVM) evaluated with leave-one-patient-out cross-validation. Feature sets combining MRI intensities, spatial descriptors, and MRSI metabolites were systematically compared. Results MRI-only models showed moderate discrimination (AUC, ≤0.70). Using MRSI features alone significantly improved prediction performance, with further improvements when extending the metabolite basis beyond conventional markers (AUC, 0.77-0.82; P < .001). Spatial descriptors and MRSI-based models provided the largest performance gains (AUC up to 0.95). SHAP analysis consistently identified both conventional and secondary metabolites among the most influential predictors, particularly in the absence of spatial features. Conclusions Postoperative MRSI and spatial descriptors significantly enhances voxel-wise prediction of GBM relapse, particularly when using an extended metabolite basis beyond conventional markers. Advances in knowledge This study supports the clinical potential of MRSI alongside spatial features to identify relapse sites not captured by anatomical MRI alone. MRSI integration of extended metabolites provides insights for voxel-wise relapse prediction, supporting complementary characterization of tissue at risk.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →